Market Overview
Ovulation is a common process that occurs in physically mature women. Ovulation tests are done to predict the levels of luteinizing hormones in women. Normally the level of luteinizing hormones increases in the urine before the process of ovulation begins. Therefore, the ovulation test is done to evaluate and predict the time of ovulation and the time when fertility is at its peak. Women mainly use ovulation tests.
One factor that mainly increases the ovulation test market is the growing population of women of reproductive age. Today, women have become independent and are opting to conceive only after the age of 30. It is a common phenomenon all over the world. May women prefer using home testing devices to do Ovulation Test Market size. This is one of the factors that has resulted in the growth of the ovulation test market as women today are aware of the medical facilities available in the market to solve their issues. This increase in awareness proves to be a good source of the rise in opportunities to the ovulation test market. Moreover, the availability of ovulation test kits on eCommerce platforms has increased the ovulation test market.
The manufacturing cost of the ovulation test kits is high and affects the ovulation test market. However, the cost of the product depends on the brand name and the material used to manufacture it. Sometimes, special features of the ovulation test kits enhance the cost of the ovulation test kit.
Competitive landscape
The major key players in the countries are:
- Fairhaven Health LLC (U.S.),
- Fertility Focus Limited (U.K.),
- NecLife (India)
- Swiss Precision Diagnostics GmbH (Switzerland),
- HiLin Life Products Inc. (U.S.)
- Geratherm Medical AG (Germany),
- Accuquik (California),
- Church & Dwight Co. Inc. (U.S.),
- Prestige Brands Holdings Inc. (U.S.),
- Clearblue (Switzerland)
- Piramal Healthcare (India)
Market Segmentation
The ovulation test market can be segmented on the test type, application, and geography. It is further divided into urine-based and saliva-based tests based on test type segmentation. According to the application or end-user category, it is further divided into clinics, home care settings, and hospitals. According to geography segmentation, the ovulation test market is divided based on location, namely North America, Europe, Asia-Pacific, and the rest of the world.
Industry news
When analyzed globally, the ovulation test market is expected to create a revenue of 18.8 USD by the end of 2028, and the expected CAGR is 3.85% from 2021 to 2028. The awareness and availability of the ovulation test kits on eCommerce platforms are some of the factors pushing the ovulation test market in increasing mode. However, an increase in the manufacture or improvisation of ovulation kits with some more benefits or reduction of the cost of the ovulation test kits may increase the ovulation test market.
Regional Classification
According to the test type segmentation, the most popular and dominating test type is a urine-based test. It contributes the maximum to the ovulation test market as it depicts the presence of HCG, which is very important to know the pregnancy status. When the application of the end-user category is analyzed, the home care settings segment dominates the ovulation test market. Other segments are popular, but home care settings segments have more benefits as it is user-friendly, easily available, and maintains women's confidentiality, which is missing in the other segments. North America contributes the maximum revenue share to the ovulation test market when the geography segment is considered.
About US:
Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
United States of America
